Related Experiment Videos
Evaluation of apolipoprotein A-I containing particles in chronic renal failure patients undergoing hemodialysis
American Journal of Nephrology
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells.
Journal of cardiovascular pharmacology·2002
Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996
The Cardiorenal Protective Effects of Low-dose Tolvaptan in Peritoneal Dialysis Patients with Volume Overload.
American journal of nephrology·2026
A new beating heart model of cardiopulmonary bypass-induced acute kidney injury demonstrates heme protein toxicity and ferroptosis.
American journal of nephrology·2026
Orforglipron and the Kidney: A Promise or Disappointment? The Need for Trials Examining Renal Outcomes.
American journal of nephrology·2026
Barriers to Person-Centered CKD Care: A Qualitative Study of Multidisciplinary Nephrology Clinicians.
American journal of nephrology·2026
Adynamic Bone Disease in Chronic Kidney Disease: From PTH Suppression-Driven Remodeling Phenotype to Osteoanabolic Therapy.
American journal of nephrology·2026